Recent years have witnessed groundbreaking developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://janaqtqm918146.blogscribble.com/39201464/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide